TrianglePUBLICATIONS · 22614995
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 Jun 20
- First author
- Pro B
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Pro B
- type
- Author
- name
- Advani R
- type
- Author
- name
- Brice P
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Illidge T
- type
- Author
- name
- Matous J
- type
- Author
- name
- Ramchandren R
- type
- Author
- name
- Fanale M
- type
- Author
- name
- Connors JM
- type
- Author
- name
- Yang Y
- type
- Author
- name
- Sievers EL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pro B
- type
- Author
- name
- Advani R
- type
- Author
- name
- Brice P
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Illidge T
- type
- Author
- name
- Matous J
- type
- Author
- name
- Ramchandren R
- type
- Author
- name
- Fanale M
- type
- Author
- name
- Connors JM
- type
- Author
- name
- Yang Y
- type
- Author
- name
- Sievers EL
- type
- Author
- bibliography ids
- nci-bib-7911b61120b71182f91b2f6e
- book metadata
- content sha256
- 45a4fc6afdd6f23b1af3ce00cdad043655c1335d6d006131aa7462d10f9e495b
- document type
- citation
- dois
- 10.1200/JCO.2011.38.0402
- electronic publication date
- display
- 2012 May 21
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22614995
- immutable id
- pubmed:22614995@45a4fc6afdd6f23b1af3ce00cdad043655c1335d6d006131aa7462d10f9e495b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 18
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2190-6
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22614995
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- ad367600ed0a5122778a2852b6c8e038c1bb6dd4a59eebdbf92e55d1ad0b0054
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Jun 20
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
Preserved source evidence · Not medical advice